BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Polak K, Bergler-Czop B, Szczepanek M, Wojciechowska K, Frątczak A, Kiss N. Psoriasis and Gut Microbiome-Current State of Art. Int J Mol Sci 2021;22:4529. [PMID: 33926088 DOI: 10.3390/ijms22094529] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Zhao X, Li J, Zhou L, Chang W, Li J, Hou R, Li J, Yin G, Li X, Zhang K. MiR-155 Inhibits TP53INP1 Expression Leading to Enhanced Glycolysis of Psoriatic Mesenchymal Stem Cells. Journal of Dermatological Science 2022. [DOI: 10.1016/j.jdermsci.2022.02.001] [Reference Citation Analysis]
2 Orsmond A, Bereza-Malcolm L, Lynch T, March L, Xue M. Skin Barrier Dysregulation in Psoriasis. Int J Mol Sci 2021;22:10841. [PMID: 34639182 DOI: 10.3390/ijms221910841] [Reference Citation Analysis]
3 Chen TL, Lin MC, Wang JH, Lin CS, Hsu CY, Loh CH. Seborrheic dermatitis and risk of incident peptic ulcer disease: A nationwide population-based cohort study. Australas J Dermatol 2021. [PMID: 34370301 DOI: 10.1111/ajd.13680] [Reference Citation Analysis]
4 Barros G, Duran P, Vera I, Bermúdez V. Exploring the Links between Obesity and Psoriasis: A Comprehensive Review. IJMS 2022;23:7499. [DOI: 10.3390/ijms23147499] [Reference Citation Analysis]
5 Zhu J, Su J. Alterations of the Gut Microbiome in Recurrent Malignant Gliomas Patients Received Bevacizumab and Temozolomide Combination Treatment and Temozolomide Monotherapy. Indian J Microbiol 2022;62:23-31. [DOI: 10.1007/s12088-021-00962-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Langan EA, Künstner A. The gastrointestinal microbiome and psoriasis: more food for thought. Br J Dermatol 2022. [PMID: 35595528 DOI: 10.1111/bjd.21618] [Reference Citation Analysis]
7 Polak K, Jobbágy A, Muszyński T, Wojciechowska K, Frątczak A, Bánvölgyi A, Bergler-Czop B, Kiss N. Microbiome Modulation as a Therapeutic Approach in Chronic Skin Diseases. Biomedicines 2021;9:1436. [PMID: 34680552 DOI: 10.3390/biomedicines9101436] [Reference Citation Analysis]
8 Liang X, Ou C, Zhuang J, Li J, Zhang F, Zhong Y, Chen Y. Interplay Between Skin Microbiota Dysbiosis and the Host Immune System in Psoriasis: Potential Pathogenesis. Front Immunol 2021;12:764384. [PMID: 34733291 DOI: 10.3389/fimmu.2021.764384] [Reference Citation Analysis]
9 Boyajian JL, Ghebretatios M, Schaly S, Islam P, Prakash S. Microbiome and Human Aging: Probiotic and Prebiotic Potentials in Longevity, Skin Health and Cellular Senescence. Nutrients 2021;13:4550. [PMID: 34960102 DOI: 10.3390/nu13124550] [Reference Citation Analysis]